Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Nephrology | Surgery | AIDS | Journal

Back to Journal Articles

Study Backs Kidney Transplants in People With HIV

Last Updated: November 17, 2010.

 

Patient, graft survival high in following years, but rejection rates unexpectedly high

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Kidney transplantation appears feasible in certain patients with HIV, though better strategies for minimizing rejection may be needed, according to research published in the Nov. 18 issue of the New England Journal of Medicine.

WEDNESDAY, Nov. 17 (HealthDay News) -- Kidney transplantation appears feasible in certain patients with HIV, though better strategies for minimizing rejection may be needed, according to research published in the Nov. 18 issue of the New England Journal of Medicine.

Peter G. Stock, M.D., of the University of California in San Francisco, and colleagues analyzed data from 150 patients with HIV infection who underwent kidney transplantation. They had CD4+ T-cell counts of 200 per cubic millimeter or higher and undetectable plasma HIV type 1 RNA levels while using a stable antiretroviral regimen.

The researchers found that rates of patient survival were 94.6 percent at one year and 88.2 percent at three years. Mean graft survival rates at these points were 90.4 and 73.7 percent, respectively. Risk of graft loss was higher in patients treated for rejection (hazard ratio, 2.8) and for those on antithymocyte globulin induction therapy (hazard ratio, 2.5). Rejection rates were higher than anticipated (one-year estimates of 31 percent and three-year estimates of 41 percent).

"Given recent advances in our understanding of the genetic predisposition to HIV-associated nephropathy, as well as the study by Stock et al. showing the feasibility of kidney transplantation, we can hope for a surge in clinical advances in the treatment of HIV-related kidney disease," writes the author of an accompanying editorial.

Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Copyright © 2010 HealthDay. All rights reserved.


Previous: VX-770 Treatment Could Hold Promise in Cystic Fibrosis Next: American College of Rheumatology, Nov. 7-11, 2010

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.